# EU HTA Vaccines

**URL:** <https://magic.discourse.group/t/eu-hta-vaccines/150>\
**Category:** Pricing & Reimbursement\
**Tags:** vaccine, eu-hta, hta, nitag\
**Created:** [April 25, 2024, 1:00pm UTC](https://magic.discourse.group/t/eu-hta-vaccines/150 "2024-04-25T13:00:44Z")\
**Posts on this page:** 2\
**Page:** 1

<div class="post-metadata">

**Author:** ![NewMagician](https://avatars.discourse-cdn.com/v4/letter/n/90ced4/32.png) [@NewMagician](https://magic.discourse.group/u/NewMagician)\
**Post date:** [April 25, 2024, 1:00pm UTC](https://magic.discourse.group/t/eu-hta-vaccines/150/1 "2024-04-25T13:00:44Z")

</div>

Hi all!  
What impact do you think EU HTA Regulation will have on the vaccines assessement? The Regulation primarily focuses on medicines and medical devices, however it does not specifically exclude vaccines. This indicates that vaccines will be included in the JCAs starting from 2030 onwards. Currently, HTA assessments for vaccines are not universally required across all EU countries.

---

<div class="post-metadata">

**Author:** ![Makemake](https://avatars.discourse-cdn.com/v4/letter/m/58956e/32.png) [@Makemake](https://magic.discourse.group/u/Makemake)\
**Post date:** [April 25, 2024, 1:45pm UTC](https://magic.discourse.group/t/eu-hta-vaccines/150/2 "2024-04-25T13:45:50Z")

</div>

And also there are NITAGs, which are involved in the vaccines assessement in some countries. I wonder if and to what extend NITAGs will be involved in the JCA process.